title: Redox potential status in children with perinatal HIV-1 infection treated with zidovudine.
authors.forename: M
authors.initials: M
authors.lastname: de Martino
authors.forename: E
authors.initials: E
authors.lastname: Zammarchi
authors.forename: L
authors.initials: L
authors.lastname: Filippi
authors.forename: M A
authors.initials: MA
authors.lastname: Donati
authors.forename: F
authors.initials: F
authors.lastname: Mannelli
authors.forename: L
authors.initials: L
authors.lastname: Galli
authors.forename: A
authors.initials: A
authors.lastname: Vierucci
mesh_terms: D020155:3-Hydroxybutyric Acid; D000090:Acetoacetates / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D015497:HIV-1; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008928:Mitochondria / Q000187:drug effects*; D010084:Oxidation-Reduction / Q000187:drug effects; D011773:Pyruvates / Q000097:blood; D019289:Pyruvic Acid; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D000090:Acetoacetates; D006885:Hydroxybutyrates; D007773:Lactates; D011773:Pyruvates; D019344:Lactic Acid; D015215:Zidovudine; C016635:acetoacetic acid; D019289:Pyruvic Acid; D020155:3-Hydroxybutyric Acid